about
Epigenetic Biomarkers in Colorectal Cancer.Significantly higher faecal counts of the yeasts candida and saccharomyces identified in people with coeliac disease.Light/Dark Shifting Promotes Alcohol-Induced Colon Carcinogenesis: Possible Role of Intestinal Inflammatory Milieu and Microbiota.The colorectal cancer immune microenvironment and approach to immunotherapies.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Environmental influences in the etiology of colorectal cancer: the premise of metabolomics.Novel insights into microbiome in colitis and colorectal cancer.Dietary factors and microRNA-binding site polymorphisms in the IL13 gene: risk and prognosis analysis of colorectal cancer.Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.PBRM1 restricts the basal activity of innate immune system through repressing RIG-I-like receptor signaling and is a potential prognostic biomarker for colon cancer.Transmission of a common intestinal neoplasm in zebrafish by cohabitation.Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice.NF-κB potentiates tumor growth by suppressing a novel target LPTS.Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something.Mucosa-associated microbiota dysbiosis in colitis associated cancer.Bacterial Metabolism Affects the C. elegans Response to Cancer Chemotherapeutics.A Mechanistic Model for Colibactin-Induced Genotoxicity.Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.The bacterial virulence factor CagA induces microbial dysbiosis that contributes to excessive epithelial cell proliferation in the Drosophila gut.Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer.Colorectal cancer: Hand-in-hand - colorectal cancer metastasizes with microorganisms.Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.The influence of diet on anti-cancer immune responsiveness.Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.Inter-niche and inter-individual variation in gut microbial community assessment using stool, rectal swab, and mucosal samples.Gut microbiome modulates efficacy of immune checkpoint inhibitors.Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer.Effect of the dietary polyacetylenes falcarinol and falcarindiol on the gut microbiota composition in a rat model of colorectal cancer.Short- and long-term evolution in our arms race with cancer: Why the war on cancer is winnable.Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction.Microbiota, Epithelium, Inflammation, and TGF-β Signaling: An Intricate Interaction in Oncogenesis.Analysis of the Gut Microbiome of Rural and Urban Healthy Indians Living in Sea Level and High Altitude Areas.Associations Between Nutrition, Gut Microbiome, and Health in A Novel Nonhuman Primate ModelRelationship of the mucosal microbiota to gastrointestinal inflammation and small cell intestinal lymphoma in catsPrognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New EvidencesRates of metachronous adenoma after curative resection for left-sided or right-sided colon cancerMicrobial Changes and Host Response in F344 Rat Colon Depending on Sex and Age Following a High-Fat DietDysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiologyChanges in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study
P2860
Q30240778-EE05C839-B3BE-420B-AB2E-DC4C1AAFEFBAQ33640334-1361642F-BE4C-4445-9E37-C43017577F27Q36213319-80DF5297-341B-4678-A82A-AA032F374D98Q38638847-2B525AC9-2B67-4DAD-A780-4CF3020DF47BQ38668187-4C93B58B-484C-4A8E-8F7B-0CE84F1FAE11Q39392886-D1886249-89EE-4D6E-805E-ECF8F6F5E478Q40064558-2024F202-5545-4468-B6A9-7C1874538E32Q40188266-20B490F7-8A65-4A5E-AE7F-D1CC4AE77680Q40248146-CECCC3E6-6854-431A-AF3B-18CDC87DBBC9Q41931705-88158B1F-E0C5-4C64-AFCD-B6D2D1E457C5Q41986568-088C3DE9-8486-43FF-AFE8-F160D50EB2DEQ42286084-D2954A46-BB8F-4C29-90D2-99E32C68167FQ42374167-62046677-AB33-4F97-96D2-4834676CB106Q44009737-8718F47D-2EE1-4F22-A8E4-54EC29AC62CFQ46306507-A18B1C6F-30F4-4897-80AA-798E90034F0BQ46379110-DAC844E3-7B1E-4FCC-8E1C-73303635DAC6Q46773646-9CC04E4E-191B-441C-9FFB-76984DA07896Q47140323-0FC3E9AF-2707-4627-AD25-BF02DBD14B5EQ47156406-EDBEE9EC-603E-40A7-8AA0-02D5E634426CQ49452061-9748FE56-299A-470E-89EA-31485EABEF90Q50018457-9D71F278-A65A-4CD3-8D15-2E07779AFECCQ50532218-DFE66806-7B0D-40F8-8DD9-3901AC44C89FQ52558651-C8564D60-823C-4FA6-9C8B-94BA56B90D61Q53700576-7243C1A7-0634-4143-A15F-DD4908472633Q55025271-ED1E5F35-3930-49A8-8C17-AD97F47A8653Q55224612-FD19EAEB-139B-4760-96A4-5A75845FF143Q55240704-F37347E2-60E7-44FD-8E47-B98DDA583E07Q55413580-2E339FF1-D43E-448A-8006-6F159C5FE844Q55439924-28DACA61-9F23-415A-B318-0CA0B6F4B775Q55465529-B5597B45-2B3C-41B1-83DE-D9B99089B81CQ55516336-9A28B0BD-3F3C-4276-A1F6-E117E001DD24Q55554558-EAFCCF9E-2221-4F8C-9AEA-58F6502527D3Q55556493-77B07166-EFB3-4A0E-8CFF-1BADFB2DD371Q56536294-F084799B-2000-4417-B88E-7490C136207BQ57099324-0B826434-0612-4A72-B555-1A6E1AD02ED3Q57191808-9F8C9388-208C-41FA-8E64-B44327F46B04Q57284277-CA974870-50A1-4C88-B575-01BCFF8B2522Q57300026-A14FE26C-B496-44DC-9C8B-A27460FDEEDDQ57822921-2624DE20-0737-4339-932D-1C07F39A1CBAQ58696034-75F378AB-FDB9-41FA-B832-E8842D66F116
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Gut Microbiota, Inflammation, and Colorectal Cancer.
@en
type
label
Gut Microbiota, Inflammation, and Colorectal Cancer.
@en
prefLabel
Gut Microbiota, Inflammation, and Colorectal Cancer.
@en
P2860
P1476
Gut Microbiota, Inflammation, and Colorectal Cancer
@en
P2093
Wendy S Garrett
P2860
P304
P356
10.1146/ANNUREV-MICRO-102215-095513
P577
2016-09-01T00:00:00Z